Programme 2019

Please find below an overview of the GMTCC track.
All sessions are tentative and subject to change.

Tuesday 14 May

10:00 - 13:00

AdvaMed Global Compliance Steering Committee Meeting (Members only)

GMTCC


MedTech Europe Ethics & Compliance Committee (ECC) Meeting (Members only)

GMTCC


13:00 - 14:00

Networking lunch

GMTCC


14:00 - 15:30

1st GMTA Global Compliance Network meeting (Members Only)

GMTCC


15:30 - 16:00

Coffee Break

GMTCC


16:00 - 17:30

1st GMTA Global Compliance Network meeting (con't) (Members Only)

GMTCC


18:00 - 21:00

MedTech Forum & GMTCC opening reception & cocktail dinner

MEDICEN MEDICEN


Wednesday 15 May

09:00 - 09:30

Gaston Berger Amphitheatre

Opening

Plenary


09:30 - 10:30

Gaston Berger Amphitheatre

CEO #nofilter

Plenary

Global leaders from the field of medical devices, diagnostics and digital health will sit together and speak openly about the latest trends, challenges and opportunities they're facing. The audience will have the opportunity to ask direct questions that will be answered with #nofilter.

10:30 - 11:00

Coffee break GMTCC

GMTCC


11:00 - 11:15

Auditorium

Keynote: view from the regulators

GMTCC

This keynote will be discussing the regulators views on the following aspects: what is working and what doesn’t with the current anti-bribery & corruption efforts; how can industry help and what are the key points for the industry to be aware of. In addition, considering that the industry is composed of more than 80% of SMEs, are there specific considerations for these companies?

11:15 - 11:35

Auditorium

Plenary session

GMTCC

The two chairwomen will discuss the AdvaMed and MedTech Europe compliance priorities as well as how these relate to the topics tackled in the MedTech Forum

11:35 - 12:50

Auditorium

Transparency: What's next for industry?

GMTCC

With the spreading transparency laws around the world, is there a need to start discussing global transparency? How can the debate move from Sunshine laws to publishing with a purpose? To help to debate this topic, it is also interesting to learn from the pharmaceutical industry what they would do better in insight; how did the public react to their disclosure; what were the main questions, and whether there are discussions to also tackle transparency at international level. The practical and operational challenges of national and international rules should also be discussed in this debate.

12:50 - 14:15

Lunch break and networking


14:15 - 15:30

Louis Armand Room East

Workshop: In vivo analysis of the MedTech Europe Code

GMTCC

Important notice: Registration to the workshop is mandatory and is only possible if both business and compliance representatives register at the same time. Registration is only open to participants duly registered to the GMTCC / MTF 2019. Thus registration will be confirmed by GMTCC Secretariat. A first-come, first-served basis policy will apply.

Description: This workshop is open to a maximum of 12 companies. Each company will have two representatives: one EMEA/European business leader and one EMEA/European  compliance officer. The group will discuss how this ambitious project has been working out, what areas need improvements or adjustments and the practical challenges encountered over the last years (e.g. speaker support, medical societies, company organized events, travel agencies, Poster presenter, CVS assessment of international events, national implementation) with regards to the MedTech Europe Code. The workshop will be moderated by chair persons of the Ethics & Compliance Committee (ECC) and Code Committee to make sure that key take aways are integrated in the future work on the Code.

Louis Armand Room West

Distributors session

GMTCCThe Red Flag Group GMTCC and The Red Flag Group

This session aims at addressing aspects such as:
- How do companies manage distributors and agents with practical implementation of the new regional codes, as well as policing of these same codes?
- Best practices in third party screening as well as engagement of new business partners
Sub-distributors/agents - what level of due diligence is being applied by companies

Auditorium

The digital transformation & compliance: Roundtable discussion with Chief Privacy Officers

GMTCC

This session aims at discussing issues arising from the new digital age and the changing business models, such as:
- What are the new risks coming for the new digital age;
- Should the compliance office become digital?
- How to ensure data stewardship, in order to deliver new products? What type of governance set up should companies think about?
- What are the privacy/data protection/GDPR considerations to keep in mind?
- Is there a role for compliance when we talk about Artificial Intelligence?
- How could open data and new technologies help to fight corruption and anti-bribery?

15:30 - 16:00

Coffee break GMTCC

GMTCC


16:00 - 18:15

Loft

Ask the experts session

GMTCC

This session will be set up in roundtable discussions. The time allocated will allow them to get to the heart of key issues. Attendance is limited to 12 persons per table. After 40 minutes, the participants are invited to switch tables. Each table lead will prepare in advance a one-pager with key topics/trends that they plan to address. After the discussions, key discussion points/outcome will be added to this one-pager and circulated to all participants

16:10 - 16:40

MedTech Forum coffee breaks and networking


Thursday 16 May

09:00 - 10:00

Gaston Berger Amphitheatre

CEO #nofilter

Plenary

Global leaders from the field of medical devices, diagnostics and digital health will sit together and speak openly about the latest trends, challenges and opportunities they're facing. The audience will have the opportunity to ask direct questions that will be answered with #nofilter

10:05 - 11:10

Auditorium

MedTech as solution providers: Compliance challenges

GMTCC

The industry has been discussing the concept of value in healthcare systems as well as what it means in terms of new commercial models for a few years, but the legal and compliance challenges that these bring along a numerous and vary depending on which part of the world you are looking at. This session aims atdiscussing the significant organisations, legal and compliance challenges in the transition from a product-driven industry to one focused on services. To help that discussion, the panel will be looking at some hypotheticals.

11:00 - 11:30

Coffee break and networking


11:30 - 12:50

Louis Armand Room West

What role for industry in supporting medical education?

GMTCC

This session aims at discussing industry’s role in supporting continuing medical education. What type of measures and programmes can be put in place to safeguard the provision of high quality, balanced medical education? What level of industry involvement is appropriate in order to allow essential interaction between the medical profession and the medical technology industry?

Auditorium

Compliance effectiveness & Risk management

GMTCC

This session aims at discussing:
- How to harness data inside of the organisation in order to support the compliance function?
- How to leverage the activities of other business parts within the same organisation?
Best practice exchange on how to measure effectiveness of key elements of compliance programs and initiatives with the data and analytics

Room 1

Best practice exchange when providing educational grants: 1,5 years after the phase out of direct sponsorship

GMTCC

This session is aimed at allowing companies to exchange of best practices in providing Educational Grants in Europe, following the ban of direct sponsorship at the beginning of 2018. How is this being managed within the different companies? How are companies monitoring compliance?

12:20 - 13:50

Lunch break and networking


14:00 - 14:40

Auditorium

Plenary session: Closing remarks & discussion

GMTCC

This closing discussion aims at reviewing the key take-aways from the last two days; how the integration of GMTCC into the MedTech Forum worked? What are the key challenges for the year ahead

14:50 - 15:40

Gaston Berger Amphitheatre

Disruptor's story

Plenary

In 2016 Onduo received half a billion dollars in funding from Verily and Sanofi to address one of the biggest problems in healthcare: diabetes. Onduo approaches diabetes care through "the marriage of technology and medicin" and hear from Onduo's CEO where they stand today

15:40 - 16:00

Gaston Berger Amphitheatre

Conclusions

Plenary


© Copyright 2018 - Europa Organisation - All rights reserved | Legal notice | Cookies | Privacy policy